Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international trial which could revolutionise care for people living with a rare and ...

Allogene Therapeutics, Inc. ( NASDAQ: ALLO) Citi's SMID Call Series 2025 October 2, 2025 1:00 PM EDT ...

The diffuse cutaneous systemic sclerosis market landscape is evolving from conventional symptom-focused strategies toward therapies that specifically target fibrosis and immune modulation, addressing ...

Patients with interstitial lung disease in systemic sclerosis demonstrate distinct intestinal microbiota that may help identify pathogenesis and targeted treatments, according to data published in ...

Cell therapy may represent a new frontier in the treatment of autoimmune diseases, with the majority of US rheumatologists reporting highly favorable ...

The partnership reflects the UAE’s growing role as a hub for medical innovation Abu Dhabi, UAE: A landmark collaboration between New York University Abu Dhabi (NYUAD), Yas Clinic – Khalifa City, and ...

NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The McDonald Diagnostic Criteria for MS - a set of guidelines to help healthcare professionals provide accurate, timely multiple sclerosis diagnosis — were ...

ABU DHABI - New York University Abu Dhabi (NYUAD), Yas Clinic- Khalifa city, and Abu Dhabi Stem Cells Centre (ADSCC) have announced a pioneering collaboration that brings new, AI-supported MRI ...

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease associated with poor quality of ...